4//SEC Filing
Rizvi Qasim 4
Accession 0001179110-19-012551
CIK 0001730430other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:58 PM ET
Size
5.4 KB
Accession
0001179110-19-012551
Insider Transaction Report
Form 4
Rizvi Qasim
Chief Commercial Officer
Transactions
- Award
Class A Common Shares
2019-12-06+30,000→ 30,000 totalExercise: $10.61Exp: 2029-12-05→ Class A Common Shares (30,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is December 9, 2019.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001794636
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 5:58 PM ET
- Size
- 5.4 KB